The central Extended Amygdala (EAc) is an ensemble of highly interconnected limbic structures of the anterior brain, and forms a cellular continuum including the Bed Nucleus of the Stria Terminalis (BNST), the central nucleus of the Amygdala (CeA) and the Nucleus Accumbens shell (AcbSh). This neural network is a key site for interactions between brain reward and stress systems, and has been implicated in several aspects of drug abuse. In order to increase our understanding of EAc function at the molecular level, we undertook a genome-wide screen (Affymetrix) to identify genes whose expression is enriched in the EAc. We focused on the less-well known BNST-CeA areas of the EAc, and identified 121 genes that exhibit more than 2-fold higher expression level in the EAc compared to whole brain. Among these, forty-three genes have never been described to be expressed in the EAc. We mapped these genes throughout the brain, using non-radioactive in situ hybridization, and identified eight genes with a unique and distinct rostro-caudal expression pattern along AcbSh, BNST and CeA. Q-PCR analysis performed in brain and peripheral organ tissues indicated that, with the exception of one (Spata13), all these genes are predominantly expressed in brain. These genes encode signaling proteins (Adora2, GPR88, Arpp21 and Rem2), a transcription factor (Limh6) or proteins of unknown function (Rik130, Spata13 and Wfs1). The identification of genes with enriched Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 
Introduction
The central Extended Amygdala (EAc) is a network formed by basal forebrain structures that include the Bed Nucleus of the Stria Terminalis (BNST) and the central Amygdala (CeA) (Alheid and Heimer, 1988 , Cassell et al., 1999 , de Olmos and Heimer, 1999 , Swanson, 2003 . However, it has been proposed that the shell of the Nucleus Accumbens (AcbSh) would be part of this network (Koob, 2003) . This particular division of the Extended Amygdala interfaces reward circuitry with stress systems, and is involved in both the acute reinforcing effects of drugs of abuse and the negative reinforcing effects of drug dependence. As such, the EAc may represent a common anatomical substrate for drug reward and stress-induced drug seeking and reinstatement (Koob, 2003 , Shaham et al., 2003 , Koob and Kreek, 2007 . The EAc receives inputs mainly from limbic cortices, and projects to the ventral tegmental area, the lateral hypothalamus, the tegmental pedunculopontine nucleus and other various brain stem nuclei (in (Koob, 2003) ). A number of transmitter systems that operate within the EAc have been described. GABA immunoreactive neurons have been characterized within the 3 components of the EAc (Sun and Cassell, 1993) . Also BNST and CeA neurons express a number of neuropeptides that include CRF, NPY, vasopressin and galanin, and modulate EAc function (see (Koob, 2003, Kash and Winder, 2006) ). However, our knowledge of phenotypic characteristics of EAc neurons remains limited.
Understanding the function of specific brain areas or circuits requires detailed information on molecules expressed by neuronals. Cellular composition and neuron function varies greatly across the brain, and large-scale gene expression studies are growing to explore gene patterning in the adult mammalian brain on a genome-wide basis. A number of transcriptome studies have examined large areas of the brain, such as the cortex, hippocampus and striatum (Bonaventure et al., 2002 , de Chaldee et al., 2003 , Ghate et al., 2007 , Stansberg et al., 2007 . Comparison of central and peripheral nervous systems has led to identify genes whose expression is restricted to either spinal cord or dorsal root ganglia (LeDoux et al., 2006) . Transcriptional imprint of 24 neural brain tissues helped to construct a gene expression-based brain map in the adult mouse (Zapala et al., 2005) . Further the exploration of specialized brain networks has provided regional-specific gene profiles using fine-dissection procedures. Genes restricted to the CA1, CA3 and DG hippocampal territories (Lein et al., 2004) , or even along the dorso-ventral axis of the CA1 field has been identified (Leonardo et al., 2006) . The analysis of subregions of the hypothalamus highlighted genes restricted to the ventromedial hypothalamus in the adult (Segal et al., 2005) or developing mouse brain (Kurrasch et al., 2007) . The study of Amygdala revealed gene subsets whose expression matched anatomical boundaries of amygdaloid nuclei (Zirlinger, 2003) . Recently Olsen and coll. compared gene profiles of the BNST to those of ventral and dorsal striatum, and identified distinct signaling and plasticity genes in these areas that all respond to dopamine and are involved in disorders ranging from Parkinson's disease to drug addiction (Olsen et al., 2008) .
The present study aimed at identifying genes with enriched expression in the EAc, in order to broaden our knowledge of genes operating within this brain network. In this study we have focused on the BNST/CeA components of the EAc. Using a micropunch-dissection procedure, we prepared a tissue sample from mouse brain CeA and BNST and compared the transcriptome in this sample to that of the whole brain. We identified 129 probe sets with a 2-fold enrichment or more in the EAc and mapped the expression pattern of 49 genes by in situ hybridization in the mouse brain. Eight genes showed an enriched expression pattern in the EAc, that we analyzed in greater details. These genes potentially influence some aspects of addictive behaviors, and may be useful for further genetic manipulations within the EAc.
Experimental procedures Tissue dissection
Tissues were dissected from male 3 to 6 month old C57Bl/6J wild-type mice using a microdissection procedure as follows. Briefly, mice were killed by cervical dislocation. Brain was removed, washed in PBS buffer and placed into a matrix cooled on ice (ASI Instruments Inc, Warren, MI, USA) to obtain slices of 1 mm thickness. Accurate localization of brain structures was based on the stereotaxic atlas of mouse brain (Paxinos and Franklin, 2001 ) and areas corresponding to the Bed Nucleus of the Stria Terminalis (BNST, +0.5 to −0.5), Central nucleus of Amygdala (CeA, −0.5 to −1.5) were taken by bilateral punches (1.2 mm diameter). BNST and CeA samples were pooled to obtain the central Extended Amygdala (EAc) sample (see Figure 1A) . Additionally, samples of the whole brain (WB), lateral hypothalamus (LH), spinal cord, thymus, lung, spleen, heart, liver, intestine, lung, stomach, kidney, testis, and lung were collected. All samples were stored at −80°C until use. All animal use procedures were in strict accordance with standard ethical guidelines (European Community Guidelines on the Care and Use of Laboratory Animals 86/609/EEC) and approved by the local ethical committee (Comité régional d'éthique en matière d'expérimentation animale de Strasbourg, CREMEAS, 2003-10-08-[1]-58).
RNA preparation and microarray hybridization
Total RNA was extracted from the different tissues using TRIzol reagent (Invitrogen, Cergy Pontoise, France) and following the manufacturer's specifications. EAc samples were prepared with tissues pooled from 3 mice, WB samples were from 2 mice. The RNA quantity was measured using a spectrophotometer and quality was assessed by agarose gel electrophoresis. For the microarray experiments, cDNA synthesis, cRNA labeling, hybridization and scanning procedures were conducted according to standard Affymetrix'protocols (www.affymetrix.com) (Affymetrix Core Facility, IGBMC, Illkirch, France, http://www-microarrays.u-strasbg.fr). Three separate hybridizations were performed with independent pooled samples from both EAc and WB. In total, 6 Mouse Genome 430 2.0 oligonucleotide arrays representing 45101 transcripts or ESTs were used in this experiment.
Microarray data analysis
Microarrays were scanned using Affymetrix GeneChip Scanner 3000. Quantification and initial analysis of the microarrays were done using Gene Chip operating Software (GCOS v1, Affymetrix UK Ltd). The comparisons of gene expression profiles between EAc and WB samples were done using a standard significance analysis (MAS 5.0 software, Affymetrix UK Ltd). For selecting differentially expressed genes, we first searched for probes considered as detected. Probe sets were eliminated in the analysis when described as absent more than 4 times among 6, or when having all signal values bellow 25 (corresponding to the median value of signals for all samples). This step led to the selection of 25174 probe sets. We then used pvalues from the MAS 5.0 comparative analysis to find probe sets, which led to acceptable False Discovery Rate (FDR). A statistical significance of 0.0025 corresponded to a FDR value of 2.5%. This threshold selected 2799 probe sets. To limit the number of genes for further analysis, we then applied more stringent criteria. We re-analyzed each hybridization set separately. We eliminated probe sets with signals under 100 in the EAc sample. We then selected probe sets with a "signal log2 ratio" of EAc/WB equal or superior to 1, corresponding to a difference in expression level of at least 2 fold. Finally, lists obtained from each hybridization set were combined and probe sets that were differentially expressed in at least 2 out of the 3 hybridizations were selected. Finally, this led to a group of 129 probe sets that we defined as enriched in the EAc. A student t-test was then performed on this subgroup to confirm that average signals from triplicate hybridizations from the EAc differed from those measured in the whole brain. Hierarchical clustering was performed on probe sets selected as enriched in the EAc using the Cluster 3.0 and Treeview software (Eisen et al., 1998 , de Hoon et al., 2004 . Genes enriched in the EAc were annotated for association with biological processes using an optimized Gene Ontology (GO) analysis (as described in (Chalmel et al., 2005 , AbouSleymane et al., 2006 , Befort et al., 2008b and with biological functions using Ingenuity Pathway Analysis (IPA) network. For GO analysis, over-represented GO terms with a probability lower than 0.01 and including at least 4 proteins were selected. In IPA analysis, biological functions and/or diseases that are most significant to the dataset were identified. The p-value for a given annotation is calculated by considering the number of "focus genes" that participate in that function and the total number of genes that are known to be associated with that process in Ingenuity's knowledge base (http://www.ingenuity.com). In our analysis, we show only the functions with the six highest p-values.
In situ hybridization
Plasmids containing candidate genes were obtained from the Deutsches Ressourcenzentrum für Genomforschung (RZPD, Berlin, Germany). Clone inserts were amplified by PCR (100 μl), using vector-specific primers and 0.25 μl of bacterial glycerol stock as template material. PCR reactions were purified using Millipore's (Millipore Corporation, Bedford, USA) Montage 96 and amplicons used as template for in-vitro transcription of sense and anti-sense Dig-labeled riboprobes. To this aim 1μg linearized DNA was transcribed using T7, T3 or Sp6 polymerases and the 10x DIG RNA labeling mix (Roche Diagnostics, Meylan, France) according to the manufacturer's instructions. Probes were quantified by spectrophotometry and quality assessed by agarose gel electrophoresis. Adult mice were killed by cervical dislocation and brains were rapidly extracted and fresh frozen in OCT. The OCT-embedded brain blocks were stored at −20°C until use. Brain sections 25 μm thick were processed for in situ hybridization using Genepaint robotic equipment and procedures (www.genepaint.org; (Carson et al., 2002) as previously described (Ghate et al., 2007) . Briefly, 600 ng of probe at a concentration of 20 ng/μl was hybridized onto the sections at 64°C for 5.5 hours. The diglabel was detected using anti-Dig-POD antibody (Roche, 1:500 dilutions in Tris-NaCl pH 7.5 solution containing Perkin Elmer blocking reagent and 0.1% Tween). The signal was amplified and revealed using tyramide amplification process-kit (Perkin Elmer, Waltham, USA) and BCIP (0.15mg/ml)/NBT (0.4 mg/ml, Roche) color substrates. Images were recorded using a CCD camera (Leica Instruments, Rueil-Malmaison, France) . In each in situ hybridization set, neuropeptide Y and preproenkephalin were used as positive controls and a blank hybridization (no probe) as the negative control. For ISH analysis, we used criteria of classification adapted from the GenePaint annotation procedures (http://www.genepaint.org/) as described in (Gofflot et al., 2007) . Three different levels of expression were defined: 0: no color precipitate detected; 1: weak expression, a few particles of color precipitate per cell; 2: strong expression, color precipitate completely filling cells. For those, we distinguished two different types of expression patterns: ubiquitous distribution throughout the brain or restricted distribution to specific regions of the brain, including EAc.
Quantitative RT-PCR
Total RNA was extracted from the different tissues using TRIzol reagent (Invitrogen, Cergy Pontoise, France) with EAc and LH samples, prepared with tissues pooled from 3 mice, whole brain samples from 2 mice and all the other tissues from individual mouse. Total RNA (2.5 μg) from each pool (n=2) was treated for 30 min at 37°C by DNase I RNase free (4 U, Invitrogen, Cergy Pontoise, France) in First strand Superscript buffer (Invitrogen, Cergy Pontoise, France) and reaction was stopped by incubating the mix 5 min at 75°C. RNA was then pre-incubated with oligodT primer (8 μM), random Hexamer (16 μM) and dNTPs (500 μM each) in a volume of 30 μl for 5 min at 65°C. Finally, First strand Superscript buffer, DTT (0,01M) and Superscript II (200U, Invitrogen, Cergy Pontoise, France) were added in final volume of 46 μl for 50 min at 42°C. Reaction was stopped by 15 min incubation at 70°C. Realtime PCR was performed in triplicate on a MyIQ BioRad instrument using iQ SYBR Green supermix, cDNA (0.5 μl) and gene-specific primers (200 nM) in a 25 μl reaction as recommended by the manufacturer (Bio-Rad, Marnes-la-Coquette, France). Gene-specific primers were designed using primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) to obtain a 75-150 bp product (see supplemental Table S1 ). Relative quantification for a given gene in any area was normalized to its level in whole brain (ΔCt) and expressed as fold change (WB level being equal to 1).
Results

Identification of genes enriched in the central Extended Amygdala
To identify genes whose expression is enriched in the EAc, we searched for genes whose expression level is higher in EAc compared to WB. We used the Genechip Mouse Genome 430 2.0 oligonucleotide arrays (Affymetrix) and compared hybridization signals of RNA transcripts in the EAc to those obtained in WB. Our gene selection procedure involved a multistep procedure based on the FDR, the gene expression level and the fold change EAc/WB (see methods). Using this approach, we identified 129 probe sets showing statistical differential expression with a fold-change of 2 at least, that we categorized as enriched in EAc (Table 1, Figure 1B ). A statistical analysis further performed directly on mean signals of each probe set (see Methods) showed that 95.3 % of the EAc probe sets were significantly enriched over whole brain (p value<0.05). Gene annotation from Affymetrix identified distinct probe sets corresponding to identical genes, with 9 genes represented by two different probe sets. In the end we identified 121 genes enriched in the EAc. Figure 1B presents a hierarchical cluster analysis of the enriched EAc transcripts with the corresponding signals in all 6 arrays.
To characterize the enriched transcriptome in the Extended Amygdala, we used a GO database and annotated the 121 genes selected, as previously described (Chalmel et al., 2005 , Befort et al., 2008b . We found 98 genes associated with proteins, among which 82 were associated with GO terms. These genes were then grouped into categories of biological processes, in which their encoded proteins are involved (GOBP) and these categories are illustrated in Figure 1C . This analysis showed that some GO categories are enriched, particularly in the response to stress (GO:0006950), behavior (GO:0007610), cell communication (GO:0007154), signal transduction (GO:0007165) and synaptic transmission (GO:0007268). Interestingly, a large group included neuropeptide signaling pathway (GO:0007218) and GPCR signaling pathway (GO:0007186) and some transcripts were also associated with neurogenesis (GO:0007399), organogenesis (GO: 00099887), central nervous system development (GO:0007417) and nerve maturation (GO:00042551). To interrogate potential functional interactions among EAc enriched genes, we also used the Ingenuity Pathways Analysis (Table 2) . Our results showed that, among the top biological functions, potential interactions were revealed by putative protein networks involved in Cell Morphology, Gene Expression, Cell Signaling and Nervous System Development and Function. Interestingly, these two bioinformatics analysis were consistent and revealed that the genes we have identified in our study participate in functions described in the literature as involving the EAc and suggest new functions for this network.
Altogether, this microarray screen identifies 23 genes that were already reported by others in EAc (see Table 1 column ISH label Litt.), some of which are widely studied (for example tachykinin 1 and 2, prodynorphin or dopamine D1 receptor). Importantly, the data also highlight a large number of genes whose expression in EAc is reported here for the first time.
Expression pattern by in situ hybridization
We further performed in situ hybridization (ISH) throughout the brain to examine expression patterns for a sub-selection of genes. We focused on 49 genes whose expression pattern in BNST and/or CeA was not studied in the mouse previously (Table 1 column ISH label S or SC). We first performed non isotopic ISH on sagittal sections of mouse brain. Our results show that a signal was detectable in the EAc for all tested probes confirming our microarray analysis (see Supplemental Figure S2 ). Expression patterns could be described as (i) low expression, (ii) strong and fairly ubiquitous expression or (iii) significant expression restricted to specific brain regions including the EAc (see Figure 2 and Methods). Altogether, 17 genes (see supplementary Figure S2A ) showed a weak signal under our hybridization conditions and those were not further investigated. Figure 2A shows sagittal ISH for three of these genes, Limh8, Dock10 and Rasgrp2 whose expression was close to the detection limit. Twenty-four other genes showed a hybridization signal widely spread along the brain (see supplementary Figure  S2B ). Figure 2B shows an example for three of these genes, namely Mrg1, Rik263, PDLIM2 with staining throughout the brain. Lastly, 8 genes were clearly detected in EAc, with weak or restricted expression in other brain regions. Figure 2C shows the sagittal expression pattern for these genes namely Limh6, Adora2, Arpp21, GPR88, Wfs1, Spata13, Rem2 and Rik130.
We next performed ISH on coronal sections for the last 8 genes (Figure 3) . We focused our analysis on sections corresponding to the EAc, at the levels of BNST ( Figure 3B ) and CeA ( Figure 3C ). As the AcbSh was proposed to be part of the Extended Amygdala (Koob, 2003) , we also included analysis of the staining observed at the level of this structure ( Figure 3A) . The expressed sequence tag RIKEN E130309F12 probe (Rik130) presented a weak expression in the AcbSh that diminished gradually rostro-caudally and no signal could be detected in the CeA. The Rad and gem related GTP binding protein 2 transcript (Rem2) was strongly expressed in the Nucleus Accumbens including shell and core, and in the interstitial nucleus of the posterior limb of the anterior commissure (IPACL), which is part of BNST. A patchy distribution in the CeA was observed and Rem2 was also clearly expressed in the dorsal striatum. Concordant with our sagittal screen, the adenosine A2 receptor gene (Adora2) showed a strong and consistent expression in all areas of the EAc network. In the BNST, the lateral division was particularly labeled ( Figure 3B ). Adenosine A2 receptor mRNA expression was also present in several brain areas such as the striatum (Cpu and core of the Nucleus Accumbens), the cortex, the hippocampus and the piriform cortex. The cyclic AMP-regulated phosphoprotein 21 gene (Arpp21) presented an interesting expression pattern, with specific mRNA expression in the AcbSh, without signal in adjacent structures like the core of the Nucleus Accumbens and the caudate putamen ( Figure 3B ). At the level of the BNST, a specific signal was detected in the medial division. No detectable staining was obtained in the CeA while the Arpp21 gene was highly expressed in the basolateral and basomedial amygdaloid nucleus. Specific signal was also measured in the medial preoptic nucleus, the cortex and the hippocampus. GPR88 gene showed strong expression throughout the striatum, including the AcbSh ( Figure 3A ). GPR88 mRNA expression was undetectable in the BNST ( Figure 3B ). A strong staining was observed in the medial division of the CeA with no signal in the basolateral Amygdala. The GPR88 mRNA was also clearly present in the piriform cortex. For the LIM homeobox 6 (Limh6) mRNA, we obtained a strong and homogenous expression throughout areas of the Extended Amygdala including AcbSh, the lateral division of the BNST and the CeA. We also noticed expression of this gene on the nucleus of the vertical limb of the diagonal band (VDB) ( Figure 3A) . A strong signal was measured for the spermatogenesis associated 13 (Spata 13) gene in the dorsal part of the lateral division of BNST compared to other BNST nuclei, as well as in the AcbSh and CeA. Additionally, a low Spata 13 staining was observed in the CA1 field of the hippocampus. Finally, the wolframin gene (Wfs1) showed strong expression throughout the Extended Amygdala. This gene was strongly expressed in the AcbSh and BNST, with a low staining in the caudate putamen. (Figure 3A and 3B) . Interestingly, expression of this gene was strong in the CeA, and extremely low in the BLA clearly defining the boundaries between these two amygdaloid nuclei ( Figure 3C ). Wolframin mRNA was also strongly expressed specifically in the CA1 field of the hippocampus and the piriform cortex.
In conclusion, these 8 genes show a specific and distinct expression pattern within the EAc. They are expressed throughout the AcbSh and CeA, and show locally restricted expression in the subdivisions of the BNST structure.
Distribution of EAc-enriched genes in the central nervous system and peripheral tissues by qPCR
To examine the general expression pattern of these 8 genes throughout the central nervous system and in peripheral organs, we performed quantitative PCR on cDNA samples from WB, EAc and LH (a brain region that we have investigated in a separate study, see Befort et al (Befort et al., 2008a) , as well as spinal cord, thymus, lung, spleen, heart, liver, intestine, stomach, kidney, testis, and muscle ( Figure 4) . The results confirmed high expression in the EAc for all the tested genes compared to whole brain. The Spata-13 gene showed the less restricted pattern of expression, with high expression levels in thymus, kidney and spleen (4.7-, 3.1-and 1.7-fold higher than in the EAc, respectively). In contrast, the GPR88 gene was detected only in the brain, with its highest level of expression in the EAc. Expression of the Rik130 transcript was restricted to the nervous system, including the spinal cord. Finally the Wfs1, Limh6, Rem2, Arpp21 and Adora2 genes showed detectable expression in several peripheral tissues, and none of the transcripts tested could be detected in muscle.
Discussion
Using Affymetrix microarrays, we have identified 129 probe-sets corresponding to 121 genes with prominent expression in the EAc. We used a strategy where gene expression in a sample from the region of interest (CeA and BNST) is compared with expression in a sample from the whole brain. Others have used a similar approach in the past, and successfully identified neuronal markers (Cahoy et al., 2008) , subregional-specific genes within mouse Amygdala nuclei (Zirlinger et al., 2001, Zirlinger and Anderson, 2003) , or regional gene markers within the several hippocampal fields (Lein et al., 2004 , Leonardo et al., 2006 . Twenty-three genes enriched in EAc have been reported earlier as being expressed in the rodent EAc (Tables 1). For example, we detected enriched expression of neuropeptide precursor genes such as preprodynorphin (3.06-fold in EAc over WB), preproenkephalin (2.81-fold in EAc over WB) or preprotachykinin 2(6.35-fold in EAc over WB) genes, whose expression patterns were described previously in specific areas of the Extended Amygdala (Harlan et al., 1987 ,Iadarola et al., 1989 ,Song and Harlan, 1994 . We also identified genes encoding myosin D (2.38-fold in EAc over WB), neuronatin (2.28-fold in EAc over WB) and myelin associated glycoprotein (2.22-fold in EAc over WB). These genes were described as specific markers of particular Amygdala nuclei in a microarray screen analysis from Zirlinger and coll (Zirlinger, 2003,Zirlinger and Anderson, 2003) . Among the top enriched genes, we finally identified the wolframin gene (3.38-fold in EAc over WB). This transcript was previously described as specifically expressed in the CA1 region of the hippocampus, and central Amygdala (Takeda et al., 2001 ,Leonardo et al., 2006 . Altogether, our identification of previously reported Amygdalar genes validates our gene selection strategy.
Importantly, literature mining indicated that expression in the EAc was unknown for 49 other genes. Our further ISH mapping analysis revealed that 8 of these genes show an expression pattern of particular interest within the EAc. We compared the expression patterns of these 8 genes with the Allen Brain Atlas (Lein et al., 2007) and, with the exception of Arpp21 and Wfs1, our analysis showed a similar pattern in the three focused areas of interest. The two expression patterns for Arpp21 transcript presented in the Allen Brain Atlas showed a more widespread expression than our ISH data. However, our ISH results were consistent with Arpp21 protein distribution in rat brain (Ouimet et al., 1989) . For the Wfs1 transcript, the pattern in the Allen Brain Atlas appeared ubiquitous, under our criteria (see methods), compared with the expression profile in the rat brain (Takeda et al., 2001) or shown here.
Altogether, with the exception of Rik130, all these genes encode a protein with either fully identified or potential function. For each of these genes, the unique and distinct expression pattern suggests a potential role in regulating the EAc network.
Spata13 showed moderate enrichment in EAc (ISH and qPCR), and was the only gene with strong expression in peripheral organs (Q-PCR) including thymus, lung or kidney. This gene (also called Asef2) was identified as a guanine-nucleotide exchange factor for Rac1 and Cdc42 (Hamann et al., 2007 , Kawasaki et al., 2007 . Rik130 was specifically expressed in the brain compared to peripheral tissues, but the expression in the EAc was quite low. No information is available on Rik130 distribution or function. A blast search in the Refprot database indicates that the Rik130 protein shows 74% homology with phosphatidic acid phosphatase type 2B (ppap2B), a gene ubiquitously and strongly expressed throughout the brain (http://brain-map.org/).
Limh6 encodes a protein belonging to the LIM homeodomain proteins, a family of transcription factors. Expression of this gene was high in brain, particularly in EA and barely detectable in the periphery. The LIM protein family is involved in many processes of CNS development, from cell fate specification to the establishment of neuronal connectivity. During embryogenesis Limh6 was found involved in the migration of cortical GABAergic interneurons (Cobos et al., 2006 , Cuzon et al., 2008 . Noticeably, several authors have proposed a role for Limh6 in the development of the Extended Amygdala in mice (Choi et al., 2005 , Garcia-Lopez et al., 2008 or zebra fish (Mueller et al., 2008) . Our Affymetrix analysis also identified Limh8, another member of the family, as a gene enriched in the EAc (Table 1) , and the expression of Limh8 was also described in the adult mouse Amygdala in another report (Zirlinger and Anderson, 2003) . These findings suggest that LIM genes, expressed in the adult brain, may contribute to remodeling of the EAc network (Grueter and Winder, 2005, Samson et al., 2005) .
Genes with a noticeable expression pattern within the EAc include four genes involved in cell signaling, namely Adora2a, the orphan GPR88, Arpp21 and Rem2. Adora2a encodes the adenosine 2A receptor, a Gs-coupled G protein coupled receptor known to be expressed in the striatum and olfactory tubercules (Santicioli et al., 1993) and involved in many brain functions (for review see (Yaar et al., 2005) ). Relevant to our finding of Adora2 expression in the EAc, previous evidence have suggested a role for Adora2 in Amygdala function. The Adora2 agonist CGS21680 was associated with an apoptosis regression in the Amygdala following myocardial infarction (Boucher et al., 2006) and a polymorphism in the human Adora2a gene was associated with panic disorders (Yamada et al., 2001 , Hamilton et al., 2004 , Lam et al., 2005 . GPR88 is an orphan G-protein coupled receptor previously reported as a striatal transcript (Mizushima et al., 2000 , Ghate et al., 2007 . In accordance, our mapping data confirm prominent expression of this gene in both EAc and the caudate putamen. GPR88 function is unknown, but the alteration of GPR88 expression was reported under several experimental conditions. GPR88 mRNA was up-regulated in the rat arcuate ventromedial nucleus during lactation (Xiao et al., 2005) , in the prefrontal cortex following metamphetamine or valpoate exposure (Ogden et al., 2004) , and down-regulated in the striatum of human patients with Huntington's disease (Hodges et al., 2006) . Arpp-21 is a cyclic AMP-regulated phosphoprotein of 21 kDa whose expression was reported in the caudate putamen and substantia nigra (Girault et al., 1990) . Arpp-21 has been associated to several aspects of dopamine signaling (Tsou et al., 1993, Ivkovic and Ehrlich, 1999) , and is down-regulated in substantia nigra of sporadic parkinsonian patients (Grunblatt et al., 2007) . Finally, Rem2 encodes a Ras-like GTPAse (Finlin et al., 2000) initially described as a modulator of N-type current in primary neuron cultures . Recently, this protein was shown to play a key role in the development of glutamatergic and GABAergic synapses in rat hippocampus primary cultures (Paradis et al., 2007) .
Most remarkable was the expression of Wfs1 gene, which showed best EAc enrichment among the final eight-gene subset. This gene appeared strongly expressed throughout the AcbSh, BNST and CeA, and weak -if no-expression was detected in most other brain regions. ISH indicated scarce expression in the caudate, olfactory tubercle, locus coeruleus, cerebellar cortex (Takeda et al., 2001 ). Our mapping study also highlighted the intriguing hippocampal expression of Wfs1, uniquely restricted to the CA1 field (see Figure 3C ) as was previously described by two groups (Takeda et al., 2001 , Leonardo et al., 2006 . Expression of Wfs1 was also detectable in the spinal cord, heart and intestine. Mutations in the Wfs1 gene are responsible for the Wolfram syndrome, an autonomous recessive disorder which is highly variable in its clinical manifestations and includes diabetes mellitus, diabetes insipidus, deafness, optic atrophy and psychiatric abnormalities (Cryns et al., 2003) . The Wfs1gene was originally characterized by positional cloning and encodes a transmembrane protein, wolframin, (Inoue et al., 1998) whose precise role in cell physiology remains to be determined. Knockout of the Wfs1 gene in mice leads to a loss of pancreatic beta-cell, suggesting a role in maintaining some populations of endocrine cells (Ishihara et al., 2004) (Riggs et al., 2005) , however the potential neurological and behavioral phenotypes of Wfs1 null mutants have not been reported as yet. Interestingly the Wfs1 messenger was up-regulated in rat Amygdala (Koks et al., 2002) and mouse pre-frontal cortex (Raud et al., 2007) when animals were exposed to cat odor, suggesting a implication of wolframin in stress responses. Together, both anatomical and functional data suggest a prominent implication of Wfs1 in emotionally related behaviors.
In conclusion, we have identified a set of genes with enriched expression in the EAc, and examined the expression pattern for a number of these genes particularly in the EAc. This study extends our knowledge of genes expressed within a brain network, which is central in reward dysregulation and stress disorders. It will be interesting to further characterize neural populations expressing these genes, and particularly to examine whether these transcripts are present in GABAergic neurons that are best characterized within the EAc (Sun and Cassell, 1993) . Additionally, BAC transgenic approaches has been used to label (Gong et al., 2003) or to isolate specific cells population in the brain (Nielsen et al., 2006 , Cahoy et al., 2008 (Cahoy et al., 2008) (Lovatt et al., 2007) . The generation of transgenic mice expressing eGFP under the control of EAc specific genes could be useful to label EAc neurons and study their function and plasticity under pathological stimulations.
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Figure 1. Affymetrix analysis for the identification of genes enriched in the EAc
(A) This scheme shows brain areas under study: bilateral punches (1.2 mm diameter) were taken from mouse brain coronal slices (1 mm thick) to collect the bed nucleus of stria terminalis (BNST, +0.5 to −0.5) and the central nucleus of the Amygdala (CeA, −0.5 to −1.5) (see Methods for details). BNST and CeA punches were pooled and corresponded to central Extended Amygdala (EAc) samples. (B) This hierarchical cluster illustrates raw microarray data from three independent hybridizations for the 129 selected probe sets, and shows high expression in EAc (right columns, red) compared to whole brain (WB, left columns, left). The probe set selection was based on a standard statistical analysis by MAS 5.0 and a threshold of 2-fold change in EAc over WB was used (see Methods for details). Hierarchical cluster analysis was performed using the Cluster 3.0 and Treeview softwares. (C) Gene ontology analysis of the EAc enriched genes. Genes were categorized with the Biological Process domain and significantly enriched GO terms with a probability lower than 0.01 and including at least four proteins are represented.
Figure 2. Expression pattern of EAc-enriched genes by in situ hybridization on sagittal brain sections
Dig-labeled RNA in situ hybridization (ISH) was performed on 25μm sagittal adult mouse brain sections 49 genes whose specific expression pattern in EAc network has not been reported earlier. In this figure, examples of low expressed genes (A), strong and ubiquitously expressed genes (B) and potential novel EAc markers (C) are shown. Neuropeptide Y (Npy) was used as a low intensity positive control, preproenkephalin (Penk) was used as a high intensity positive control and a blank hybridization was used as the negative control (D). Representative images are shown, and the complete ISH analysis on sagittal sections for all 49 genes is shown in supplemental Figure S2 . Expression patterns were classified as detailed in methods. Gene symbols are indicated as in Table 1 . Quantitative PCR reactions were performed in triplicate on 2 independent samples (3 mice pooled for EAc, 2 mice pooled for WB and individual n=2 mice all other tissues, see Methods for details) and data are expressed as a fold-change over WB considered as the reference sample. Each gene is represented by a single box row, with expression levels illustrated using a grey scale from white (low level) to black (high level). All the genes are mainly expressed in the central nervous system (CNS), with the exception of Spata-13 expressed in most tested tissues at levels similar or higher to CNS. 
EAc-enriched genes
This table shows the list of 129 probe sets selected from the Affymetrix analysis, with high expression in EAc compared to whole brain (WB). Data are expressed as fold-change of EAc over WB, with corresponding p values from the MAS5.0 analysis (Affy p-value). A FDR of 2.5% was used for the initial selection of probe sets (see details in Methods). Student t-test was further performed to compare mean signals for EAc versus WB data and validate the selection. Probe sets whose expression was investigated in this study by in situ hybridization (ISH) on sagittal (S) or coronal (C) sections are indicated (see Figures 2, 3 and Supplemental Figure 1 ). Gene encoding a glial protein (Gli) or previously described in EAc using ISH analysis (Litt) have been identified from literature mining and are also indicated in the Top gene networks identified in Ingenuity Pathway analysis. Number of genes and corresponding top functions for which expression is higher in the Extended Amygdala as compared to the whole brain. 
